Back to
Susquehanna International Group, LLP
QNCX
Showing 5 of 19 quarters
Position history for
Susquehanna International Group, LLP's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, Susquehanna International Group held 172,640 shares of QNCX (Quince Therapeutics), worth $17,506. Susquehanna International Group's 13F filings listed QNCX from Q4 2025 to Q1 2026, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$25,268
Total Shares Change
-32,553
Quarter-by-Quarter History